Is there need to search for alternatives to indomethacin for hemicrania continua? Case reports and a review

Sanjay Prakash1, Mahammed Husain, Dhara S Sureka

  • 1Department of Neurology, Medical College, SSG Hospital, Baroda, Gujarat 390001, India. drprakashs@yahoo.co.in

Insights

Hemicrania continua (HC) is a challenging headache disorder. Topiramate shows promise as an alternative treatment for patients intolerant to indomethacin, offering relief from severe head pain.

Area of Science:

  • Neurology
  • Headache Medicine

Background:

  • Hemicrania continua (HC) is characterized by continuous unilateral headaches with superimposed severe exacerbations and autonomic features.
  • Indomethacin responsiveness is key to HC diagnosis, but significant side effects limit its use.
  • Managing HC requires exploring alternatives due to indomethacin's adverse effects and the chronic nature of the condition.

Observation:

  • This study reports two cases of Hemicrania continua successfully managed with topiramate.
  • Topiramate provided significant relief in patients experiencing severe head pain and autonomic symptoms.

Findings:

  • Topiramate is a viable alternative treatment for Hemicrania continua, particularly for individuals intolerant to indomethacin.
  • The findings suggest topiramate can effectively manage the debilitating symptoms of HC.

Implications:

  • Topiramate offers a new therapeutic option for Hemicrania continua patients, improving quality of life.
  • Further research into topiramate and other indomethacin alternatives is warranted for long-term HC management.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...